10.1016/j.obpill.2024.100127 [DOI] [PMC free article] [PubMed] [Google Scholar] 3.Nauck MA, Meier JJ (2016) The incretin effect in healthy individuals and those with type 2 diabetes: physiology, pathophysiology, and response to therapeutic interventions
Such practices are essential to ensure patient safety and well-being while navigating the complexities of obesity management and its potential psychiatric implications
These drugs affect several digestive and appetite-regulating hormones, so the body may take time to adjust
Yes, GLP-1 medications help people eat less but for many, thats exactly the breakthrough
If they are, you have reason to continue
Bando Y, Ogawa A, Ishikura K et al (2017) The effects of ipragliflozin on the liver-to-spleen attenuation ratio as assessed by computed tomography and on alanine transaminase levels in Japanese patients with type 2 diabetes mellitus